AVTX

AVALO THERAPEUTICS INC

AVTX·05338F306·US·Common Stock·Healthcare - Biotechnology-13D/G

AVTX (AVALO THERAPEUTICS INC) is held by 54 institutional investors as of Q1 2026. Largest holders: FMR LLC ($43M), Avoro Capital Advisors LLC ($21.1M), UBS Group AG ($17M). Net institutional sentiment: Mixed.

54
Holders
Avg rating(8 Elite)
$256.6M
Total Value
64% (62)
Fund Consensus
38 buying - 21 selling
AVTXSmart Money Verdict
View all
Held by 54 funds
8 elite
Who's Trading
ActivistMillennium Management LLCMillennium Management LLC0.0%Jul 6, 2026
InsiderDMDoyle MittieSell $93KJun 30, 2026
InsiderDMDoyle MittieSell $26KJun 23, 2026
ActivistCOCommodore Capital LP9.9%Jun 18, 2026
ActivistFMR LLCFMR LLC6.1%Jun 5, 2026
ActivistDTDeep Track Capital, LP5.8%May 29, 2026
InsiderDMDoyle MittieSell $11KMay 28, 2026
ActivistPoint72 Asset Management, L.P.Point72 Asset Management, L.P.5.2%May 26, 2026
ActivistAvoro Capital Advisors LLCAvoro Capital Advisors LLC5.8%May 15, 2026
InsiderSRSullivan Christopher RyanExercise 19K shMay 7, 2026
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
2.9M(+1207.1%)$43M0.0%+2.34%
47
New
1.4M$21.1M0.2%+1.91%
48
Increased
1.1M(+139.0%)$17M0.0%+6.47%
46
Increased
916,142(+46.0%)$13.7M0.0%+29.30%
38
New
916,000$13.7M0.1%+1.91%
39
New
856,962$12.8M0.1%+1.91%
46
Increased
854,000(+55.3%)$12.8M0.0%+14.83%
39
Increased
835,484(+26.6%)$12.5M0.0%+11.42%
35
Increased
731,586(+66.5%)$10.9M0.0%+25.15%
41
New
719,694$10.7M0.0%+1.91%
38
Unchanged
662,968$9.9M0.1%+104.36%
0
Increased
643,000(+3.5%)$9.6M0.0%+135.75%
29
Decreased
470,775(-1.0%)$7M0.0%+7.86%
0
Increased
455,000(+764.4%)$6.8M0.0%+2.56%
44
Increased
422,781(+113.8%)$6.3M0.0%+4.61%
44
Increased
327,082(+12.9%)$4.9M0.0%+47.69%
30
Decreased
193,735(-53.8%)$2.9M0.0%+47.54%
0
Increased
194,391(+337.5%)$2.7M0.0%+3.44%
42
Increased
174,506(+170.7%)$2.6M0.0%+4.03%
42
Decreased
173,320(-3.1%)$2.6M0.0%+7.86%
0

Showing 1-20 of 62

1 / 4

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used